Innovation Pharmaceuticals Inc (IPIX)

[BonelessCat]

The least dilutive and highest value way to bring multiple drugs to market is to license one following successful Phase 2 or ahead of Phase 3 trials to pay for the remaining pipeline. Anything else, other than the appearance of an angel, is pure greed and folly. I've watched too many try to go it alone and fail. Please look at Polymedix as a very good example of going it alone when there is an entire stable to exploit during times when flush to pay for a lead platform.

$500 million over 3 to 5 years with a backend royalty of 15% should be enough for anyone when there are 6 more drugs against as many diseases in the pipe just waiting for trials and approval to market.